Sirish Palle to Child
                            
                            
                                This is a "connection" page, showing publications Sirish Palle has written about Child.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.632
         
        
        
     
 
    
        
        - 
            A Comparison of Novel Serum Markers of Liver Health in Adolescents With Metabolic Dysfunction-Associated Steatotic Liver Disease. J Cell Mol Med. 2025 Aug; 29(16):e70817.
            
            
                Score: 0.153
            
         
        
        - 
            Racial disparities in presentation and outcomes of paediatric autoimmune hepatitis. Liver Int. 2019 05; 39(5):976-984.
            
            
                Score: 0.098
            
         
        
        - 
            Approach to a Child with Colitis. Indian J Pediatr. 2016 Nov; 83(12-13):1444-1451.
            
            
                Score: 0.080
            
         
        
        - 
            Oxidized high-density lipoprotein and low-density lipoprotein in adolescents with obesity and metabolic dysfunction-associated steatotic liver disease. Pediatr Obes. 2025 Feb; 20(2):e13194.
            
            
                Score: 0.037
            
         
        
        - 
            Serum adropin is unaltered in adolescents with histology-confirmed steatotic liver disease. J Pediatr Gastroenterol Nutr. 2025 Jan; 80(1):182-188.
            
            
                Score: 0.036
            
         
        
        - 
            Concordance of MASLD and NAFLD nomenclature in youth participating in the TARGET-NASH real-world cohort. Hepatol Commun. 2024 Nov 01; 8(11).
            
            
                Score: 0.036
            
         
        
        - 
            Postprandial triglycerides and fibroblast growth factor 19 as potential screening tools for paediatric non-alcoholic fatty liver disease. Pediatr Obes. 2023 04; 18(4):e13007.
            
            
                Score: 0.032
            
         
        
        - 
            A two decade long study of disease progression of de novo and recurrent autoimmune hepatitis in the pediatric population. Pediatr Transplant. 2021 Aug; 25(5):e13978.
            
            
                Score: 0.028
            
         
        
        - 
            The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children. Hepatology. 2021 03; 73(3):1074-1087.
            
            
                Score: 0.028
            
         
        
        - 
            Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms. Nutrients. 2020 Oct 16; 12(10).
            
            
                Score: 0.027
            
         
        
        - 
            Assessing the Validity of Adult-derived Prognostic Models for Primary Sclerosing Cholangitis Outcomes in Children. J Pediatr Gastroenterol Nutr. 2020 01; 70(1):e12-e17.
            
            
                Score: 0.026
            
         
        
        - 
            Epidemiology, Clinical Presentation, and Seasonal Variation in the Diagnosis of Children with Eosinophilic Esophagitis in Oklahoma. South Med J. 2020 01; 113(1):37-41.
            
            
                Score: 0.026
            
         
        
        - 
            Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical Course. J Pediatr. 2019 06; 209:92-96.e1.
            
            
                Score: 0.025